Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study.
Interdisciplinary health team
Psoriasis
Psoriatic arthritis
Spondyloarthritis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
25
02
2022
accepted:
25
03
2022
pubmed:
19
4
2022
medline:
25
5
2022
entrez:
18
4
2022
Statut:
ppublish
Résumé
The aim of this study was to assess the patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis (PsA) referred to a combined Dermatology-Rheumatology (Derm-Rheum) Clinic. This was a retrospective study of patients seen in a combined Derm-Rheum Clinic (February 2018 to June 2020) in a Tertiary University Hospital. Consecutive patients with suspicious musculoskeletal symptoms or a known diagnosis of PsA referred to the Derm-Rheum Clinic were examined and followed simultaneously by experienced dermatologists and rheumatologists. Among 151 patients with psoriasis (PSO) with suspicious musculoskeletal complaints, 129 (85%) with a final diagnosis of PsA were included (56% females, mean age: 55 years, median disease duration: 14.2 years). In 62% of these patients (n = 94), PsA was diagnosed for the 1st time. At initial evaluation, 95% had peripheral arthritis, 45% nail involvement, 23% axial involvement, 12% enthesitis and 6% dactylitis with a median DAPSA and PASI scores of 20.5 and 1.6, respectively. 31% of the patients were not receiving any systemic treatment, 45% were on biologics, 29% on non-biologics and 10% on targeted synthetic agents (apremilast). At last visit (median interval time: 15 months), only 8% did not receive any systemic therapy (p < 0.001 compared to 1st visit), 62% were on biologics (p = 0.009 compared to 1st visit), 46% on non-biologics (p = 0.01 compared to 1st visit) and 10% remained on apremilast. The median DAPSA and PASI scores decreased significantly to 5.3 and 0, respectively. In conclusion, about 2/3 of patients with PSO and musculoskeletal complaints referred to a combined Derm-Rheum Clinic were diagnosed for the 1st time with PsA. During follow-up, the percentage of PsA patients on systemic therapies significantly increased with major improvement of disease activity indices. These data emphasize the value of combined Derm-Rheum Clinics for earlier referral, diagnosis, and more effective treatment of PsA patients.
Identifiants
pubmed: 35435445
doi: 10.1007/s00296-022-05126-z
pii: 10.1007/s00296-022-05126-z
doi:
Substances chimiques
Biological Products
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1035-1041Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Ogdie A, Weiss P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am 41:545–568. https://doi.org/10.1016/j.rdc.2015.07.001
doi: 10.1016/j.rdc.2015.07.001
pubmed: 26476218
pmcid: 4610151
Papadavid E, Katsimbri P, Kapniari I et al (2016) Prevalence of psoriatic arthritis and its correlates among patients with psoriasis in Greece: results from a large retrospective study. J Eur Acad Dermatol Venereol 30:1749–1752. https://doi.org/10.1111/jdv.13700
doi: 10.1111/jdv.13700
pubmed: 27508394
Gladman DD, Shuckett R, Russell ML et al (1987) Psoriatic arthritis (PSA)–an analysis of 220 patients. Q J Med 62:127–141
pubmed: 3659255
Scher JU, Ogdie A, Merola JF, Ritchlin C (2019) Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol 15:153–166. https://doi.org/10.1038/s41584-019-0175-0
doi: 10.1038/s41584-019-0175-0
pubmed: 30742092
Schett G, McInnes IB, Neurath MF (2021) Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med 385:628–639. https://doi.org/10.1056/NEJMra1909094
doi: 10.1056/NEJMra1909094
pubmed: 34379924
Gladman DD, Thavaneswaran A, Chandran V, Cook RJ (2011) Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis 70:2152–2154. https://doi.org/10.1136/ard.2011.150938
doi: 10.1136/ard.2011.150938
pubmed: 21914627
Tillett W, Jadon D, Shaddick G et al (2013) Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis 72:1358–1361. https://doi.org/10.1136/annrheumdis-2012-202608
doi: 10.1136/annrheumdis-2012-202608
pubmed: 23291384
Haroon M, Gallagher P, FitzGerald O (2015) Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74:1045–1050. https://doi.org/10.1136/annrheumdis-2013-204858
doi: 10.1136/annrheumdis-2013-204858
pubmed: 24525911
Elmets CA, Leonardi CL, Davis DMR et al (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 80:1073–1113. https://doi.org/10.1016/j.jaad.2018.11.058
doi: 10.1016/j.jaad.2018.11.058
pubmed: 30772097
Velez NF, Wei-Passanese EX, Husni ME et al (2012) Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Arch Dermatol Res 304:7–13. https://doi.org/10.1007/s00403-011-1172-6
doi: 10.1007/s00403-011-1172-6
pubmed: 21904925
Luchetti MM, Benfaremo D, Campanati A et al (2018) Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic. Clin Rheumatol 37:2741–2749. https://doi.org/10.1007/s10067-018-4238-4
doi: 10.1007/s10067-018-4238-4
pubmed: 30056525
Argobi Y, Smith GP (2021) Analysis of the first 5 years of an interdisciplinary rheumatology-dermatology clinic. Clin Exp Dermatol 46:270–275. https://doi.org/10.1111/ced.14390
doi: 10.1111/ced.14390
pubmed: 32687656
Hjuler KF, Dige A, Agnholt J et al (2021) Effectiveness of interdisciplinary combined dermatology-gastroenterology-rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a parallel group, non-blinded, pragmatic randomised trial. BMJ Open 11:e041871. https://doi.org/10.1136/bmjopen-2020-041871
doi: 10.1136/bmjopen-2020-041871
pubmed: 33910945
pmcid: 8094387
Okhovat JP, Ogdie A, Reddy SM et al (2017) Psoriasis and psoriatic arthritis clinics multicenter advancement network consortium (PPACMAN) survey: benefits and challenges of combined rheumatology-dermatology clinics. J Rheumatol 44:693–694. https://doi.org/10.3899/jrheum.170148
doi: 10.3899/jrheum.170148
pubmed: 28461529
Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673
doi: 10.1002/art.21972
Ogdie A, Rozycki M, Arndt T et al (2021) Longitudinal analysis of the patient pathways to diagnosis of psoriatic arthritis. Arthritis Res Ther 23:252. https://doi.org/10.1186/s13075-021-02628-2
doi: 10.1186/s13075-021-02628-2
pubmed: 34598717
pmcid: 8485539
Mease PJ, Gladman DD, Helliwell P et al (2014) Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 71:649–655. https://doi.org/10.1016/j.jaad.2014.05.010
doi: 10.1016/j.jaad.2014.05.010
pubmed: 24974240
Al Rayes H, Alazmi M, Attar S et al (2022) Consensus-based recommendations on the diagnosis, referral and clinical management of patients with psoriatic arthritis. Rheumatol Int 42:391–401. https://doi.org/10.1007/s00296-021-05029-5
doi: 10.1007/s00296-021-05029-5
pubmed: 34716785
Gratacos-Masmitja J, Luelmo-Aguilar J, Zarco-Montejo P et al (2017) Points to consider in the foundation of multidisciplinary units for psoriatic arthritis: a delphi study and a systematic review of the literature. Adv Ther 33:2150–2159. https://doi.org/10.1007/s12325-016-0429-z
doi: 10.1007/s12325-016-0429-z
pubmed: 27757814
Gordon KB, Ruderman EM (2006) The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach. J Am Acad Dermatol 54:S85-91. https://doi.org/10.1016/j.jaad.2005.10.052
doi: 10.1016/j.jaad.2005.10.052
pubmed: 16488334
Mody E, Husni ME, Schur P, Qureshi AA (2007) Multidisciplinary evaluation of patients with psoriasis presenting with musculoskeletal pain: a dermatology: rheumatology clinic experience. Br J Dermatol 157:1050–1051. https://doi.org/10.1111/j.1365-2133.2007.08139.x
doi: 10.1111/j.1365-2133.2007.08139.x
pubmed: 17725678
Salvarani C, Girolomoni G, Di Lernia V et al (2016) Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis. Semin Arthritis Rheum 46:305–311. https://doi.org/10.1016/j.semarthrit.2016.06.004
doi: 10.1016/j.semarthrit.2016.06.004
pubmed: 27470190
Radtke MA, Reich K, Blome C et al (2009) Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 23:683–691. https://doi.org/10.1111/j.1468-3083.2009.03159.x
doi: 10.1111/j.1468-3083.2009.03159.x
pubmed: 19309433
Karmacharya P, Wright K, Achenbach SJ et al (2021) Diagnostic delay in psoriatic arthritis: a population-based study. J Rheumatol 48:1410–1416. https://doi.org/10.3899/jrheum.201199
doi: 10.3899/jrheum.201199
pubmed: 33589556
Guillen Astete CA, Gaite Gonzalez I, Zurita Prada PA, Urrego Laurin C (2021) Delay and diagnostic pathway of patients with psoriatic arthritis in Spain. Reumatol Clin (Engl Ed) 17:525–529. https://doi.org/10.1016/j.reumae.2020.05.004
doi: 10.1016/j.reumae.2020.05.004
Ogdie A, Nowell WB, Applegate E et al (2020) Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States. BMC Rheumatol 4:2. https://doi.org/10.1186/s41927-019-0102-7
doi: 10.1186/s41927-019-0102-7
pubmed: 31938764
pmcid: 6953285
Armstrong AW, Robertson AD, Wu J et al (2013) Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003–2011. JAMA Dermatol 149:1180–1185. https://doi.org/10.1001/jamadermatol.2013.5264
doi: 10.1001/jamadermatol.2013.5264
pubmed: 23945732
Armstrong AW, Koning JW, Rowse S et al (2017) Under-treatment of patients with moderate to severe psoriasis in the united states: analysis of medication usage with health plan data. Dermatol Ther (Heidelb) 7:97–109. https://doi.org/10.1007/s13555-016-0153-2
doi: 10.1007/s13555-016-0153-2
Lambert J, Ghislain PD, Lambert J et al (2017) Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER). J Dermatolog Treat 28:394–400. https://doi.org/10.1080/09546634.2016.1255304
doi: 10.1080/09546634.2016.1255304
pubmed: 27791446
Ingrasciotta Y, Isgro V, Ientile V et al (2021) Are Patients with psoriasis and psoriatic arthritis undertreated? A population-based study from Southern Italy. J Clin Med 10:3431. https://doi.org/10.3390/jcm10153431
doi: 10.3390/jcm10153431
pubmed: 34362214
pmcid: 8348176
Mease PJ, Gladman DD, Papp KA et al (2013) Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 69:729–735. https://doi.org/10.1016/j.jaad.2013.07.023
doi: 10.1016/j.jaad.2013.07.023
pubmed: 23981683
Boehncke WH, Horvath R, Dalkilic E et al (2020) Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study. J Eur Acad Dermatol Venereol 34:2035–2043. https://doi.org/10.1111/jdv.16251
doi: 10.1111/jdv.16251
pubmed: 32003056
Zusman EZ, Howren AM, Park JYE et al (2020) Epidemiology of depression and anxiety in patients with psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 50:1481–1488. https://doi.org/10.1016/j.semarthrit.2020.02.001
doi: 10.1016/j.semarthrit.2020.02.001
pubmed: 32178850
Karmacharya P, Ogdie A, Eder L (2021) Psoriatic arthritis and the association with cardiometabolic disease: a narrative review. Ther Adv Musculoskelet Dis 13:1759720X21998279. https://doi.org/10.1177/1759720X21998279
Ziob J, Behning C, Brossart P et al (2021) Specialized dermatological-rheumatological patient management improves diagnostic outcome and patient journey in psoriasis and psoriatic arthritis: a four-year analysis. BMC Rheumatol 5:45. https://doi.org/10.1186/s41927-021-00217-z
doi: 10.1186/s41927-021-00217-z
pubmed: 34715940
pmcid: 8556909
Husted JA, Thavaneswaran A, Chandran V, Gladman DD (2013) Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol 40:1349–1356. https://doi.org/10.3899/jrheum.121500
doi: 10.3899/jrheum.121500
pubmed: 23772076